Innovent Biologics Inc
Change company Symbol lookup
Select an option...
IVBXF Innovent Biologics Inc
STEM Stem Inc
ZIM ZIM Integrated Shipping Services Ltd
METC Ramaco Resources Inc
NVTS Navitas Semiconductor Corp
TRIP Tripadvisor Inc
RKT Rocket Companies Inc
BBVA Banco Bilbao Vizcaya Argentaria SA
F Ford Motor Co
AVLR Avalara Inc
Go


Based in China
Company profile

Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical products, and provision of consultation and research and development services. The Company's main product is Tyvyt (sintilimab injection), which is used to treat relapsed or refractory classical Hodgkin’s lymphoma. The Company's products also include adalimumab biosimilar IBI-303, which is used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. Bevacizumab biosimilar IBI-305 is used to treat metastatic colorectal cancer and advanced, metastatic or recurrent non-small-cell lung cancer (NSCLC). Rituximab biosimilar IBI-301 is used to treat non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Its products are used in oncology, metabolic, immunology and ophthalmology diseases.

Price
Delayed
$4.67
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 0 shares is on pace to be much lighter than IVBXF's 10-day average volume of 10,693 shares.

0

INVESTIGATION ALERT: Halper Sadeh LLP Investigates VMW, TPTX, CTT, CTEK

9:46 am ET June 9, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / June 9, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

VMware, Inc. (NYSE:VMW)'s sale to Broadcom Inc. Under the terms of the merger, VMware shareholders may elect to receive either $142.50 in cash or 0.2520 shares of Broadcom common stock for each share of VMware they own. The shareholder election is subject to proration. If you are a VMware shareholder, click here to learn more about your rights and options.

Turning Point Therapeutics, Inc. (NASDAQ:TPTX)'s sale to Bristol Myers Squibb for $76.00 per share. If you are a Turning Point shareholder, click here to learn more about your rights and options.

CatchMark Timber Trust, Inc. (NYSE:CTT)'s sale to PotlatchDeltic Corporation for 0.23 common shares of PotlatchDeltic stock for each common share of CatchMark. If you are a CatchMark shareholder, click here to learn more about your rights and options.

CynergisTek, Inc. (NYSE:CTEK)'ssale to Clearwater Compliance LLC for $1.25 per share in cash.If you are a CynergisTek shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLP, Thursday, June 9, 2022, Press release picture

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP





View source version on accesswire.com:

https://www.accesswire.com/704504/INVESTIGATION-ALERT-Halper-Sadeh-LLP-Investigates-VMW-TPTX-CTT-CTEK



comtex tracking

COMTEX_408434148/2457/2022-06-09T09:46:21

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.